Investigating how to restore immune cells in the brain affected by Lewy body disease
Repopulation of the Microglia/Macrophage Niche in Experimental Lewy Body Disease
This study is looking at how a protein linked to Lewy body disorders affects the brain, especially in areas that control smell and memory, and it’s testing a new oral medication that might help boost the brain's immune system to clear out these harmful proteins and improve brain health.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duquesne University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11038250 on NIH RePORTER |
What this research studies
This research focuses on understanding Lewy body disorders, which are neurodegenerative diseases characterized by the accumulation of a protein called α-synuclein in the brain. The study uses a rodent model to explore how these protein aggregates affect brain function, particularly in areas related to smell and memory. Researchers aim to enhance the brain's immune response by repopulating specific immune cells, known as microglia and macrophages, using a medication that can be taken orally. This approach may help in clearing the harmful aggregates and improving brain health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lewy body disorders or those exhibiting early signs of neurodegeneration.
Not a fit: Patients with advanced stages of Lewy body disease or those with other unrelated neurodegenerative conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the brain's ability to combat Lewy body disease and improve cognitive functions.
How similar studies have performed: Previous research has shown promise in using similar approaches to enhance immune responses in neurodegenerative diseases, indicating potential for success in this area.
Where this research is happening
Pittsburgh, United States
- Duquesne University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Leak, Rehana Khan — Duquesne University
- Study coordinator: Leak, Rehana Khan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.